PI
AZN icon

PFG Investments’s AstraZeneca AZN Stock Holding History

PFG Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
2,725
+175
+7% +$32.9K 0.02% 650
2026
Q1 		$503K Sell
2,550
-364
-12% -$70.2K 0.02% 598
2025
Q4 		$536K Buy
2,914
+261
+10% +$45.8K 0.03% 551
2025
Q3 		$407K Buy
2,653
+68
+3% +$10.3K 0.02% 632
2025
Q2 		$361K Buy
2,585
+332
+15% +$46.5K 0.02% 650
2025
Q1 		$331K Sell
2,253
-239
-10% -$34.6K 0.02% 647
2024
Q4 		$326K Sell
2,492
-30
-1% -$4.2K 0.02% 667
2024
Q3 		$393K Sell
2,522
-19
-0.7% -$3.07K 0.03% 586
2024
Q2 		$396K Buy
2,541
+405
+19% +$60.9K 0.03% 541
2024
Q1 		$289K Buy
2,136
+524
+33% +$69.4K 0.02% 754
2023
Q4 		$217K Buy
+1,612
New +$210K 0.04% 430

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PFG Investments's AZN Position: Q2 2026 in Review

PFG Investments increased its AstraZeneca (AZN) stake by 6.9% in Q2 2026, buying an estimated $32.9K and bringing the position to 2,725 shares worth $517K. The position accounts for 0.02% of the portfolio, ranked #650.

PFG Investments first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $536K in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • PFG Investments held 2,725 shares of AstraZeneca worth $517K as of Q2 2026.
  • PFG Investments bought 175 AstraZeneca shares in Q2 2026, an estimated $32.9K.
  • AstraZeneca made up 0.02% of PFG Investments's portfolio in Q2 2026, its #650 holding.
  • PFG Investments first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
  • PFG Investments's AstraZeneca position peaked at $536K in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.